↓ Skip to main content

Dove Medical Press

Therapeutic Potential of Dupilumab in the Treatment of Chronic Rhinosinusitis with Nasal Polyps: Evidence to Date

Overview of attention for article published in Therapeutics and Clinical Risk Management, January 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news
1 news outlet
policy
1 policy source
twitter
2 X users
video
2 YouTube creators

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
68 Mendeley
Title
Therapeutic Potential of Dupilumab in the Treatment of Chronic Rhinosinusitis with Nasal Polyps: Evidence to Date
Published in
Therapeutics and Clinical Risk Management, January 2020
DOI 10.2147/tcrm.s210648
Pubmed ID
Authors

Jean Kim, Robert Naclerio

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 68 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 9 13%
Other 7 10%
Researcher 6 9%
Student > Ph. D. Student 5 7%
Student > Doctoral Student 4 6%
Other 10 15%
Unknown 27 40%
Readers by discipline Count As %
Medicine and Dentistry 25 37%
Biochemistry, Genetics and Molecular Biology 3 4%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Nursing and Health Professions 2 3%
Business, Management and Accounting 1 1%
Other 4 6%
Unknown 30 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 February 2023.
All research outputs
#2,419,461
of 25,387,668 outputs
Outputs from Therapeutics and Clinical Risk Management
#109
of 1,323 outputs
Outputs of similar age
#57,108
of 473,316 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#2
of 17 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 473,316 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.